Pathfinder Nanosponges for Drug Targeting by Factorial Design:

A Glance Review

 

Hindustan Abdul Ahad*, Haranath Chintaginjala, Syed Rahamathulla,

Aswarthanarayana Rupasree, Anegondithimmappa Sajan Kumar, Barji Prasanna Pallavi

Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research

(RIPER)- Autonomous, KR Palli Cross, Cheyyedu-515721, Ananthapuramu, Andhra Pradesh, India.

*Corresponding Author E-mail: abdulhindustan@gmail.com

 

ABSTRACT:

For a long time, drug delivery systems (DDS) have been targeted to get expected results. With nanotechnology-based DDS, a wide assortment of flawless challenges can be tackled at present. Known as a nanosponge, a nanosponge is a modern division of material consisting of tiny particles that transmit only a few nanometers. The nano-formulations are highly effective for the delivery of low-solubility drugs. Many drugs with narrow therapeutic windows can benefit from improving water solubility. It has even been claimed they can be utilized to target and control delivery. In addition, huge amounts of money have been spent on developing new formulations of the DDS in recent times. Learn how nanosponges are prepared, its advantages, and its disadvantages. Resources were consulted to comprehend recent enhancements and patents in the domain. The ideal DDS has been developed by combining many different formulations; nano sponges are one of them. Analysts have examined them and found that they produce positive results and can improve the stability of poorly water-soluble drugs. The drug will be released at the precise target site when it reaches the body and sticks to the surface of the target site. As medication maximum action declines, it is more difficult to formulate impotent drugs. Considering this, nanosponges are organized and examined to determine whether they are problematic. Nanosponges in drug delivery can be characterized by their characteristics, preparation, factors, and applications. The article was written based on research articles about nanosponges. Data on nanosponges drug delivery systems from the past decade was collected using a factorial design. Study authors report that factor design plays an imperative role in optimizing drug dosage forms. Researchers will save time by reviewing the literature on nanosponges via factorial designs instead of searching for it.

 

KEYWORDS: Targeted, Nanosponges, Drug Delivery, Polymers, Design.

 

 


 

INTRODUCTION:

The nanosponges (NS) resemble viruses with a naturally degradable scaffold. It forms a spherical shape whose cavities (caries) can enclose the drug. Polyesters are biodegradable, meaning they can release drugs when they break down in the body. Delivering drugs directly to the lungs, liver, and spleen is possible with nanosponges. Also, they can be used for transporting biocatalysts, proteins, enzymes, and antibodies. By targeting drugs to specific sites, preventing degradation of those drugs and proteins, and prolonging their release, it can prevent drug interactions. Nanosponges, in combination with cyclodextrin, offer more drug loading than other nanocarriers when used in topical formulations1.

 

Nanosponges enclose drug molecules inside nanoparticles. These are 3 types of nanoparticles viz., encapsulating, conjugating, and complex. A nanosponge or nanocapsule acts as a carrier for encapsulated nanoparticles. The biocompatibility and adaptability of nanosponges have significant benefits for pharmaceutical applications. Providing protection against premature degradation for drugs encapsulated in nanosponge cavities, their stability is improved. Drug molecules are contained in the cavities (caries) in alginate nanoparticles, unlike sponges. Secondly, there are nanoparticles conjugated with drugs via covalent bonds. Nanoparticles of the third type are attracted by electrostatic charges2.

 

One can administer them orally, parenterally, topically, or inhalationally. They are more stable than other nanoparticles. They can transport an extensive diversity of substances due to the nanometric cavities (caries) in their three-dimensional arrangement and the tunable polarity of their surfaces. In addition, nanoparticles have an advantage over other nanoparticles because they can be easily rejuvenated by methods such as washing with biocompatible solvents, denudation with moderately inert hot gases, or altering ionic strength. Both crystallinity and paracrystalline are possible. Crystallization is the primary process leading to nanosponges. A paracrystalline nanosponge's ability to store drugs varies. The amount of crosslinker in the polymer can be varied to manufacture nanosponges of a specific size, which release drugs over time. Cyclodextrins with polymeric branches have been revealed to be beneficial in pharmaceutical applications3.

 

Advantages of Nanosponges:

Below is a list of nanosponges' BENEFITS and pitfalls4.

·      In addition to hydrophobic molecules within the hydrophobic cavities, nanosponges can also carry hydrophilic molecules within the gap amid the hydrophobic molecules. Hydrophobic drugs can be loaded into the nanosponge structure to consequently increase their solubility.

·      Nanosponges can be used to deliver drugs in a controlled manner.

·      It is easily scaled up for economic production and is biodegradable by nature.

·      A transport fluid composed of sodium hydroxide and water is used for transportation. They can be used to produce undesirable tastes.

·      Drugs are protected from degradation.

·      Aside from the fact that it's non-irritating, it's non-toxic.

·      In this case, the side effects are less severe.

 

Disadvantages of Nanosponges:

·      Small molecules are the strength of nanosponges.

·      Only consider storing capacities.

·      Retarded release may occur.

·      Both crystalline and paracrystalline nanosponges are possible.

 

Preparation of Nanosponges:

Nanosponges, nanostructured materials, can be organized by crosslinking polyester with crosslinking agents. There are several ways to prepare nanosponges5.

 

Melt Method

Solvent diffusion method

Emulsion solvent diffusion method

Quasi-emulsion solvent diffusion

Solvent method

Ultrasound Assisted Method

Fig. 1: Various methods of preparing nanosponges

 

Advantages of Factorial Design in Nanosponges:

With a factorial design, a researcher can control multiple independent variables at the same time. We can analyze the effects of independent variables individually and together in this design. Factorial design is more effective than single-factor design. In factorial design, we can determine the independent or main effect of independent variables and the collective effect of two or more independent variables. Factorial experiments provide more extensive results and can be generalized more widely since several independent variables are manipulated at the same time6.


 

Table 1: Past work done on nano sponges using factorial design

 Drug

Design

Independent Variable

Dependant Variable

Terbinafine HCl7

32 Full Factorial Design (FFD)

EC (X1) and the stirring rate (X2)

Particle size (PS) (Y1) and Entrapment efficiency (EE) (Y2)

Curcumin and caffeine8

32 FFD

Carbopol-934 (X1) and β-CD (X2)

Viscosity (Y1) and % drug release (DR) (Y2)

Praziquantel9

23 FFD

EC (X1), PVA (X2) and Stirring speed (X3)

Drug loading (Y1), PS (Y2), and %DR (Y3)

Lornoxicam10

32 FFD

EC (X1) and PVA (X2)

EE (Y1) and DR (Y2)

Paracetamol, Aceclofenac, Caffeine11

33 BBD

Polymer concentration (X1), Crosslinker (X2), and reaction time (X3)

PS (Y1) and EE (Y2)

Risedronate sodium12

32 FFD

EC (X1) and PVA (X2)

PS (Y1) and EE (Y2)

Acyclovir13

23 FD

PVA (X1), Eudragit (X2) and Stirring speed (X3)

EE, % yield (PY) (Y2), PS(Y3), and DR(Y4)

Itraconazole14

32 FFD

EC (X1) and PVA (X2)

EE (Y1), DC(Y2), and PY(Y3)

Quercetin15

32 FFD

EC (X1), PVA (X2), HPMC (X3), and Carbopol 934 (X4)

PS(Y1), polydispersity index (PDI), zeta potential (ZP), and EE

Fluconazole16

32 FFD

EC (X1) and PVA (X2)

EE(Y1), PS(Y2), and DR(Y3)

Tizanidine HCl17

32 FFD

β-CD (X1) and carbopol 934 (X2)

PS(Y1), PY (Y2), EE (Y3), and ZP (Y4)

5-Fluoro uracil18

32 FFD

EC(X1), PVA (X2) and Poloxamer- 407 (X3)

DC(Y1), EE (Y2), and ZP (Y3)

Doxorubicin19

32 FFD

EC (X1) and PVA (X2)

DC(Y1), PS (Y2), PDI (Y3), EE (Y4), and DR (Y5)

Nifidipine20

32 FFD

EC (X1), PVA (X2), and β-CD (X3)

DC (Y1), PY (Y2), and EE (Y3)

Naproxen and Ibuprofen21

32 FFD

EC (X1) and PVA (X2)

PY (Y1), EE (Y2), DC (Y3), PS (Y4), PDI (Y5), and ZP (Y6)

Flubriprofen22

32 FFD

β-CD (X1), PVA (X2)

EE (Y1) and DR (Y2)

Trimethoprim23

BBD

β-CD (X1),

DC (Y1), DS (Y2), and EE (Y3)

Indomethacin24

32 FFD

EC (X1) and PVA (X2)

EE (Y1)

Atorvastatin25

32 FFD

EC (X1), PVA (X2), and β-CD (X3)

PY (Y1), DR (Y2), and EE (Y3)

Glipizide26

32 FFD

EC (X1), PVA (X2), and β-CD (X3)

DC (Y1), EE (Y2), PS (Y3), and DR (Y4)

Miconazole nitrate27

32 FFD

Sodium CMC (X1), Carbopol 934 (X2), HPMC (X3), MC (X4)

Mucoadhesive time (MT) (Y1)

Clotrimazole28

32 FFD

Pluronic F-127 (X1) and Pluronic F-68 (X2)

Gelation temperature (Y1), gelation time (Y2) and DR(Y3)

Lemongrass29

32 FFD

EC (X1), PVA (X2) and the stirring rate (X3)

PS (Y1) and DR (Y2)

Paclitaxel30

24 FD

Bovine serum albumin (X1) and stirring speed (X2)

EE (Y1), PS (Y2), and DR (Y3)

Ciprofloxacin31

32 FFD

EC (X1) and PVA (X2)

EE (Y1)

Voriconazole32

32 FFD

Pluronic F-68 (X1), Poly methyl methacrylate (X2), EC (X3), PVA (X4) Carbopol 971P (X5)

EE (Y1) and DR (Y2)

 


 

CONCLUSION:

The study concludes that water solubility is important for drugs with a narrow therapeutic window, and it is required to get targeted/controlled delivery. To resolute this Nanosponges were evolved in addition to other novel drug delivery systems. The evidence for the relevance of nanosponges has been compiled from published research papers. Data from the past decade about nanosponge’s drug delivery systems was analyzed using a factorial design. Researchers from the study found that the factor design technique is important for optimizing the dosage form for drug delivery. Since researchers will not have to search for literature on nanosponges, reviewing literature by factorial design will save time.

 

CONFLICT OF INTEREST:

The authors declare no conflict of interest.

 

ACKNOWLEDGMENT:

The authors are thankful to RERDS-CPR of RIPER for providing the facilities for doing this work.

 

REFERENCES:

1.     Ghose A, Nabi B, Rehman S, Md S, Alhakamy NA, Ahmad OA, Baboota S, Ali J. Development and Evaluation of Polymeric Nanosponge Hydrogel for Terbinafine Hydrochloride: Statistical Optimization, In Vitro and In Vivo Studies. Polymers. 2020; 12(12): 2903.

2.     Abdul AH, Bala AG, Chintaginjala H, Manchikanti SP, Kamsali AK, Dasari RR. Equator Assessment of Nanoparticles Using the Design-Expert Software. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020 Jan 31; 13(1): 4766-72.

3.     Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. Journal of Pharmacy and Pharmaceutical Sciences. 2012 Jan 17; 15(1): 103-11.

4.     Chinthaginjala H, Abdul H, Reddy AP, Kodi K, Manchikanti SP, Pasam D. Nanosuspension as Promising and Potential Drug Delivery: A Review. (2020). Int. J. Life Sci. Pharma Res.; 11(1): P59-66.

5.     Shravani Y, Ahad HA, Haranath C, gari Poojitha B, Rahamathulla S, Rupasree A. Past Decade Work Done on Cubosomes Using Factorial Design: A Fast-Track Information for Researchers. (2021). Int. J. Life Sci. Pharma Res.; 11(1): P124-135.

6.     Amer RI, El-Osaily GH, Gad SS. Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation. Journal of advanced pharmaceutical technology and research. 2020 Jan; 11(1): 13.

7.     Reham I. Amer,Ghada H.El-osaily and Sameh S.Gad Design and Optimization of topical Terbinafine Hydrochloride nanosponges: Application of full factorial design, in vitro and vivo evaluation Journal of Advanced Pharmaceutical Technology and Research 2020 Jan-Mar; 11(1): 13-19.

8.     Iriventi P, Gupta NV, Osmani RA, Balamuralidhara V. Design and development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. DARU Journal of Pharmaceutical Sciences. 2020 Dec; 28: 489-506.

9.     Bagade OM, Dhole SN, Chaudhari PD. An Influence of Lyophilization on Praziquantel Loaded Nanosponge’s by using food protein as a stabilizer with effect of Statistical Optimization. Nuclear magnetic resonance. 2020 Sep 1; 8: 10.

10.   Shawky SM, Khalifa MK, Eassa HA. Lornoxicam-loaded nanosponges for controlled anti-inflammatory effect: in vitro/in vivo assessment. International Journal of Applied Pharmaceutics. 2020 Nov 7: 217-23.

11.   Moin A, Roohi NF, Rizvi SM, Ashraf SA, Siddiqui AJ, Patel M, Ahmed SM, Gowda DV, Adnan M. Design, and formulation of polymeric nanosponge tablets with enhanced solubility for combination therapy. RSC Advances. 2020; 10(57): 34869-84.

12.   Shah NV, Gohil DY, Seth AK, Aundhia CJ, Patel SS. Development of Risedronate Sodium-loaded Nanosponges by Experimental Design: Optimization and in vitro Characterization. Indian Journal of Pharmaceutical Sciences. 2019 Mar 27; 81(2): 309-16.

13.   Dev A, Dwivedi J, Momin M. Quality by Design based formulation and evaluation of acyclovir microsponges. Journal of Drug Delivery and Therapeutics. 2019 Jan 11; 9(1): 54-60.

14.   Ghurghure SM, Ka K, Ys T, Ma P. Preparation, and in-vitro evaluation of Itraconazole loaded nanosponges for topical drug delivery. Indo Am J Pharm Res. 2019; 9: 1999-2013.

15.   Sujitha YS, Muzib YI. Formulation and optimization of quercetin loaded nanosponges topical gel: ex vivo, pharmacodynamic and pharmacokinetic studies. International Journal of Applied Pharmaceutics. 2019 Sep 7: 156-65.

16.   Abbas N, Parveen K, Hussain A, Latif S, uz Zaman S, Shah PA, Ahsan M. Nanosponge-based hydrogel preparation of fluconazole for improved topical delivery. Tropical Journal of Pharmaceutical Research. 2019 Mar 11; 18(2): 215-22.

17.   Silpa GS, Mathan S, Dharan SS. Formulation and Evaluation of Nanosponges Loaded Hydrogel Using Different Polymers Containing Selected Antifungal Drug. Journal of Pharmaceutical Sciences and Research. 2021 Feb 1; 13(2): 101-11.

18.   Arun Raj R, Thomas S. Development and Characterization of 5-Fluorouracil Cubosomal Nanosponge Tablet for Colon Targeting. Journal of Pharmaceutical Scienes 2019 Vol-10(2) Pages: 9-18.

19.   Narender BR, Rao PR. Formulation and evaluation of anticancer drug (doxorubicin) loaded nanosponges. Indo American journal of Pharmaceutical Research 2019; 9(12): 572-583.

20.   El Assal MI, El Assal MI. Nano-sponge novel drug delivery system as carrier of anti-hypertensive drug. Int J Pharm Pharm Sci. 2019 Oct 1; 11: 47-63.

21.   Abbas N, Irfan M, Hussain A, Arshad MS, Hussain SZ, Latif S, Bukhari NI. Development and evaluation of scaffold-based nanosponge formulation for controlled drug delivery of naproxen and ibuprofen. Tropical Journal of Pharmaceutical Research. 2018 Oct 5; 17(8): 1465-74.

22.   Pavani A, Rama B. Formulation, and in Vitro characterization of flurbiprofen nanosponges. Int J Res Pharm Chem [Internet]. 2018;8(4):577-82.

23.   Divya PS, Chacko AJ. Formulation and evaluation of trimethoprim loaded nanosponge ocular in-situ gel. International Journal of Pharmacy and Pharmaceutical Journals. 2018; 13(3): 158-71.

24.   Abbas N, Sarwar K, Irfan M, Hussain A, Mehmood R, Arshad MS, Shah PA. Formulation, and evaluation of indomethacin loaded nanosponges for oral delivery. Acta Poloniae Pharmaceutica-Drug Research. 2018; 75(5): 1201-13.

25.   Solunke RS, Borge UR, Murthy K, Deshmukh MT, Shete RV. Formulation and evaluation of gliclazide nanosponges. International journal of applied pharmaceutics. 2019 Nov 7: 181-9.

26.   Arvapally S, Harini M, Harshitha G, Arun Kumar A. Formulation, and in vitro evaluation of glipizide nanosponges. Am J Pharmtech Res. 2017; 7: 341-61.

27.   Kumar PS, Hematheerthani N, Ratna JV, Saikishore V. Design and characterization of miconazole nitrate loaded nanosponges containing vaginal gels. Int J Pharm Ana Res. 2016; 5(3): 410-7.

28.   Karthick RA, Devi DR, Hari BV. Investigation of sustained release mucoadhesive in-situ gel system of Secnidazole for the persistent treatment of vaginal infections. Journal of Drug Delivery Science and Technology. 2018 Feb 1; 43: 362-8.

29.   Aldawsari HM, Badr-Eldin SM, Labib GS, El-Kamel AH. Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: in vitro/in vivo evaluation. International journal of nanomedicine. 2015; 10: 893.

30.   Bhoskar M, Patil P. Development and evaluation of paclitaxel loaded nanoparticles using 24 factorial designs. Int J Curr Pharm Res. 2015; 7: 64-72.

31.   Raja CH, Kumar GK, Anusha K. Fabrication, and evaluation of ciprofloxacin loaded nanosponges for sustained release. Int J Res Pharm Nano Sci. 2013; 2: 1-9.

32.   Srinivas P, Sreeja K. Formulation, and evaluation of voriconazole loaded nanosponges for oral and topical delivery. Int J Drug Dev Res. 2013 Jan; 5(1): 55-69.

 

 

 

Received on 19.08.2021       Modified on 07.09.2021

Accepted on 22.09.2021     ©A&V Publications All Right Reserved

Res. J. Pharma. Dosage Forms and Tech.2021; 13(4):341-344.

DOI: 10.52711/0975-4377.2021.00055